Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Gano Kyle, the Chief Executive Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $15.4 billion biopharmaceutical company currently rated as having GREAT financial health according to ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

Q4 2024 Management View CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent, Libtayo, and EYLEA HD. He emphasized the acceleration in EYLEA ...

The approval was based on a Phase 3 study showing significant reductions in daily OFF time and increases in GOOD ON time. Supernus CEO Jack Khattar expressed the company's commitment to developing ...

United Therapeutics Corp. announced Feb. 4. that it will start a trial in mid-2025 with six patients who have end-stage renal disease. These patients, who have been on dialysis for at least six months ...

Nuance Audio showcased its glasses with built-in hearing aids at CES 2025. Now that the product is FDA-approved, it will be available in the US in the coming months.

Altria Group Inc. chief executive Billy Gifford told tobacco analysts it "has become clear that two markets exist in the U.S.

Trump’s White House juggled a devastating American Airline flight-Black Hawk helicopter crash, a Chinese AI threat and looming tariffs just this week alone, making for a busy start to his four-year ...

Bobbie co-founder and CEO Laura Modi says 15-minute meetings and wartime ballads help her get more done at work and home.